WO2001058410A3 - A method of treating colon cancer by administering apigenin, luteolin, diosmetin and crysin - Google Patents
A method of treating colon cancer by administering apigenin, luteolin, diosmetin and crysin Download PDFInfo
- Publication number
- WO2001058410A3 WO2001058410A3 PCT/US2001/004656 US0104656W WO0158410A3 WO 2001058410 A3 WO2001058410 A3 WO 2001058410A3 US 0104656 W US0104656 W US 0104656W WO 0158410 A3 WO0158410 A3 WO 0158410A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chrysin
- administering
- glucuronosyltransferase
- udp
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001236982A AU2001236982A1 (en) | 2000-02-11 | 2001-02-12 | A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18207200P | 2000-02-11 | 2000-02-11 | |
US60/182,072 | 2000-02-11 | ||
US23277100P | 2000-09-15 | 2000-09-15 | |
US60/232,771 | 2000-09-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001058410A2 WO2001058410A2 (en) | 2001-08-16 |
WO2001058410A3 true WO2001058410A3 (en) | 2002-01-24 |
Family
ID=26877757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/004656 WO2001058410A2 (en) | 2000-02-11 | 2001-02-12 | A method of treating colon cancer by administering apigenin, luteolin, diosmetin and crysin |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001236982A1 (en) |
WO (1) | WO2001058410A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006105725A1 (en) * | 2005-04-05 | 2006-10-12 | Shanghai Gloriayx Biopharmaceuticals Co., Ltd | A combination of luteolin and one of pt chemotherapeutics |
GB201407694D0 (en) * | 2014-05-01 | 2014-06-18 | Univ Montfort | Compound |
CN104208598A (en) * | 2014-09-26 | 2014-12-17 | 禤燕华 | Chinese medicinal composition for treating chronic jaundice |
CN106389405A (en) * | 2015-07-30 | 2017-02-15 | 中国科学院大连化学物理研究所 | A class of glucuronosyltransferase UGT1A1 inducers and applications thereof |
CN114053414A (en) * | 2021-12-31 | 2022-02-18 | 大连医科大学 | Application of flavonoid compound USP22 inhibitor in preparation of anti-tumor immunity medicine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126129A (en) * | 1988-05-23 | 1992-06-30 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Cancer therapy using interleukin-2 and flavone compounds |
US5858371A (en) * | 1997-02-05 | 1999-01-12 | Panacea Biotech Limited | Pharmaceutical composition for the control and treatment of anorectal and colonic diseases |
WO1999021550A1 (en) * | 1997-10-24 | 1999-05-06 | Bio-Monde Preparations Limited | Use of coumarin derivatives for the treatment of digestive tract disorders |
US6087385A (en) * | 1998-10-30 | 2000-07-11 | University Of Mississippi | Flavonoid derivatives |
-
2001
- 2001-02-12 AU AU2001236982A patent/AU2001236982A1/en not_active Abandoned
- 2001-02-12 WO PCT/US2001/004656 patent/WO2001058410A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126129A (en) * | 1988-05-23 | 1992-06-30 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Cancer therapy using interleukin-2 and flavone compounds |
US5858371A (en) * | 1997-02-05 | 1999-01-12 | Panacea Biotech Limited | Pharmaceutical composition for the control and treatment of anorectal and colonic diseases |
WO1999021550A1 (en) * | 1997-10-24 | 1999-05-06 | Bio-Monde Preparations Limited | Use of coumarin derivatives for the treatment of digestive tract disorders |
US6087385A (en) * | 1998-10-30 | 2000-07-11 | University Of Mississippi | Flavonoid derivatives |
Non-Patent Citations (1)
Title |
---|
KLOSS J.: "Back to Eden", March 1972, BEREFICIAL BOOKS, NEW YORK, US, XP002943606 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001058410A2 (en) | 2001-08-16 |
AU2001236982A1 (en) | 2001-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG170119A1 (en) | Nutritional composition comprising indigestible oligosaccharides | |
MY125821A (en) | Pharmaceutical composition of topiramate | |
BRPI0114042B8 (en) | use of bicyclic compound in the manufacture of a composition for the relief or prevention of constipation in a constipated human patient and bowel cleansing | |
HUP0204546A2 (en) | Carbohydrate formulation for enhancement of immune response | |
HUP0203437A3 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
TR200101895T2 (en) | Treatment of sexual ailments. | |
NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
HK1051490A1 (en) | Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs. | |
WO2001058410A3 (en) | A method of treating colon cancer by administering apigenin, luteolin, diosmetin and crysin | |
UA66856C2 (en) | Thienopyrimidines, a method for the preparation thereof, a pharmaceutical composition and a method for the preparation thereof | |
HUP0203303A3 (en) | Compositions for administering taxanes orally to human patients | |
EP0965344A4 (en) | Prophylactic and therapeutic agent for inflammatory intestinal diseases | |
IL132992A0 (en) | Method and compositions for administering taxanes orally to human patients | |
NO20021160D0 (en) | constituents | |
BR0107960A (en) | Treatment of allergic and inflammatory conditions | |
BR0212249A (en) | Compound, pharmaceutical composition, method of treatment or prophylaxis of diseases, and use of a compound | |
EP1136492A4 (en) | Sulfonamide compounds and uses thereof as medicines | |
AU2002366645A8 (en) | Compositions for the treatment of lupus, other rheumatic diseases and joint diseases | |
NZ505933A (en) | Incorporation of cholesterol lowering agents into confectionery dosage forms | |
Matsukawa et al. | High biliary excretion levels of quercetin metabolites after administration of a quercetin glycoside in conscious bile duct cannulated rats | |
WO2002076400A3 (en) | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | |
WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
EP1341550A4 (en) | Method for treating respiratory distress syndrome | |
WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
MEP1108A (en) | Use of specific dose of fondaparinux sodium for the treatment of acs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |